Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Flunisolide, etc.); Correction, 56858 [2010-23195]

Download as PDF 56858 Federal Register / Vol. 75, No. 180 / Friday, September 17, 2010 / Rules and Regulations smallest possible testing pool is 10 different people, the total testing pool for a particular school consists of all knowledge tests, practical tests, and end-of-course tests for approved appendix K that were administered in the prior 24-month period. For those schools that seek renewal of nonprovisional pilot school certificates, they must continue to meet, by reference in § 141.83, the quality of training standard set forth in § 141.5(d). This rule clarifies existing requirements and reinserts language that was inadvertently removed. Because the changes in this technical amendment result in no substantive change, we find good cause exists under 5 U.S.C. 553(d)(3) to make the amendment effective in less than 30 days. List of Subjects in 14 CFR Part 141 Administrative practice and procedure, Air carriers, Aircraft, Aviation safety, Charter flights, Reporting and recordkeeping requirements. The Amendment Accordingly, title 14 of the Code of Federal Regulations (CFR) part 141 is amended as follows: ■ PART 141—PILOT SCHOOLS 1. The authority citation for part 141 continues to read as follows: ■ Authority: 49 U.S.C. 106(g), 40113, 44701– 44703, 44707, 44709, 44711, 45102–45103, 45301–43502. 2. Amend § 141.5 by revising paragraphs (d) and (e) to read as follows: ■ § 141.5 Requirements for a pilot school certificate. wwoods2 on DSK1DXX6B1PROD with RULES_PART 1 * * * * * (d) Has established a pass rate of 80 percent or higher on the first attempt for all knowledge tests leading to a certificate or rating, practical tests leading to a certificate or rating, or endof-course tests for an approved training course specified in appendix K of this part. (e) Has graduated at least 10 different people from the school’s approved training courses. Issued in Washington, DC on September 14, 2010. Pamela Hamilton-Powell, Director, Office of Rulemaking. [FR Doc. 2010–23283 Filed 9–16–10; 8:45 am] BILLING CODE 4910–13–P VerDate Mar<15>2010 14:39 Sep 16, 2010 ACTION: 20 CFR Part 416 SUMMARY: [Docket No. SSA–2009–0017] RIN 0960–AH00 Improvements to the Supplemental Security Income Program—Heroes Earnings Assistance and Relief Tax Act of 2008 (HEART Act) Social Security Administration. Final Rule; correcting amendment. AGENCY: ACTION: In the Federal Register of September 7, 2010, we published a final rule document revising our regulations to incorporate improvements to the Supplemental Security Income (SSI) program made by the HEART Act. We inadvertently stated the RIN incorrectly as 0960–AD78. This document corrects the RIN to 0960–AH00. DATES: Effective on September 17, 2010. FOR FURTHER INFORMATION CONTACT: Brian J. Rudick, Office of Regulations, Social Security Administration, 6401 Security Boulevard, Baltimore, MD 21235–6401, (410) 965–7102. For information on eligibility or filing for benefits, call our national toll-free number, 1–800–772–1213, or TTY 1– 800–325–0778, or visit our Internet site, Social Security Online, at https:// www.socialsecurity.gov. SUPPLEMENTARY INFORMATION: We published a final rule document in the Federal Register of September 7, 2010, (75 FR 54285) revising our regulations to incorporate improvements to the SSI program made by the HEART Act. In this final rule, we incorrectly stated the RIN as 0960–AD78. This correction changes the RIN to 0960–AH00. SUMMARY: The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of April 14, 2010 (75 FR 19213). The document amended FDA’s regulation on the use of ozone-depleting substances (ODSs) in self-pressurized containers to remove the essential-use designations for flunisolide, triamcinolone, metaproterenol, pirbuterol, albuterol and ipratropium in combination, cromolyn, and nedocromil used in oral pressurized metered-dose inhalers (MDIs). The document was published with an inadvertent error. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Diane Sullivan, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 3210, Silver Spring, MD 20993, 301–796– 9171. In FR Doc. 2010–8467, appearing on page 19213, in the Federal Register of Wednesday, April 14, 2010, the following correction is made: 1. On page 19213, in the third column, the heading ‘‘RIN 0910–AF92’’ is corrected to read ‘‘RIN 0910–AF93’’. SUPPLEMENTARY INFORMATION: Dated: September 13, 2010. David Dorsey, Acting Deputy Commissioner for Policy, Planning and Budget. [FR Doc. 2010–23195 Filed 9–16–10; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF THE TREASURY Internal Revenue Service 26 CFR Parts 1 and 602 Martin Sussman, Senior Advisor for Regulations. [TD 9502] [FR Doc. 2010–23183 Filed 9–16–10; 8:45 am] RIN 1545–BF90 BILLING CODE 4191–02–P Exclusions From Gross Income of Foreign Corporations DEPARTMENT OF HEALTH AND HUMAN SERVICES AGENCY: Food and Drug Administration 21 CFR Part 2 [Docket No. FDA–2006–N–0304] (formerly Docket No. 2006N–0262) RIN 0910–AF93 Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Flunisolide, etc.); Correction AGENCY: PO 00000 Food and Drug Administration, Frm 00002 Fmt 4700 Internal Revenue Service (IRS), Treasury. ACTION: Final regulations and removal of temporary regulations. This document contains final regulations under section 883(a) and (c) of the Internal Revenue Code (Code), concerning the exclusion from gross income of income derived by certain foreign corporations from the international operation of ships or aircraft. The final regulations adopt the proposed regulations issued on June 25, 2007, (REG–138707–06) with certain modifications in response to comments SUMMARY: HHS. Jkt 220001 Final rule; correction. SOCIAL SECURITY ADMINISTRATION Sfmt 4700 E:\FR\FM\17SER1.SGM 17SER1

Agencies

[Federal Register Volume 75, Number 180 (Friday, September 17, 2010)]
[Rules and Regulations]
[Page 56858]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-23195]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 2

[Docket No. FDA-2006-N-0304] (formerly Docket No. 2006N-0262)
RIN 0910-AF93


Use of Ozone-Depleting Substances; Removal of Essential-Use 
Designation (Flunisolide, etc.); Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a final 
rule that appeared in the Federal Register of April 14, 2010 (75 FR 
19213). The document amended FDA's regulation on the use of ozone-
depleting substances (ODSs) in self-pressurized containers to remove 
the essential-use designations for flunisolide, triamcinolone, 
metaproterenol, pirbuterol, albuterol and ipratropium in combination, 
cromolyn, and nedocromil used in oral pressurized metered-dose inhalers 
(MDIs). The document was published with an inadvertent error. This 
document corrects that error.

FOR FURTHER INFORMATION CONTACT:  Diane Sullivan, Office of Policy, 
Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 
3210, Silver Spring, MD 20993, 301-796-9171.

SUPPLEMENTARY INFORMATION: In FR Doc. 2010-8467, appearing on page 
19213, in the Federal Register of Wednesday, April 14, 2010, the 
following correction is made:
    1. On page 19213, in the third column, the heading ``RIN 0910-
AF92'' is corrected to read ``RIN 0910-AF93''.

    Dated: September 13, 2010.
David Dorsey,
Acting Deputy Commissioner for Policy, Planning and Budget.
[FR Doc. 2010-23195 Filed 9-16-10; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.